Clinical Enzymology in Cancer

References

• Warburg O. Metabolism of Tumors, F. Dickens. Constable, London 1930
   Google Scholar
• Warburg O. On the origin of cancer cells. Science 1956; 123: 309
   PubMed Web of Science ®Google Scholar
• Warburg O. On respiratory impairment in cancer cells. Science 1956; 124: 269
   PubMed Web of Science ®Google Scholar
• Weinhouse S. Enzyme systems in tumor cells. Enzymes in Health and Disease, D. M. Greenberg, H. A. Harper. Charles C Thomas, Springfield, Ill. 1960; 191
   Google Scholar
• Aisenberg A. C. The Glycolysis and Respiration of Tumors. Academic Press, New York 1961
   Google Scholar
• Foulds L. Neoplastic Development. Academic Press, London 1969; Vol. 1
   Google Scholar
• Knox W. E., III. Quantitative enzyme changes in differentiation and carcinogenesis. Biological Interactions in Normal and Neoplastic Growth. Little, Brown, Boston 1962
   Google Scholar
• Boxer G. E. Glycolytic enzymes in human tumors: difficulties, methods, and results. Eur. J. Cancer 1965; 1: 161
   Google Scholar
• Wilson P. D. Characterization of spontaneous and induced epithelial and mesenchymal tumours by their enzyme patterns. J. Pathol. 1974; 113: 151
   PubMed Web of Science ®Google Scholar
• Weber G. Enzymology of cancer cells. N. Engl. J. Med. 1977; 296: 486–541
   PubMed Web of Science ®Google Scholar
• Farron F., Hsu H. T. T., Knox W. E. Fetal-type isoenzymes in hepatic and non-hepatic rat tumors. Cancer Res. 1972; 32: 302
   PubMed Web of Science ®Google Scholar
• Langvad E. Lactate dehydrogenase isoenzyme patterns in bronchogenic carcinoma. Eur. J. Cancer 1968; 4: 107
   Google Scholar
• Oliver J. A., El Hilali M. M., Belitsky P., MacKinnon K. J. LDH isoenzymes in benign and malignant prostate tissue. Cancer 1970; 25: 863
   PubMed Web of Science ®Google Scholar
• Weinhouse S. Isozymes in cancer. Cancer Res. 1971; 31: 1166
   PubMed Web of Science ®Google Scholar
• Gerhardt W. Changes of LDH-isozymes, esterases, and acid phosphatases and proteins in malignant and benign human brain tumors. Acta Neurol. Scand. 1963; 39: 85
   PubMed Web of Science ®Google Scholar
• Nathanson L., Fishman W. H. New observations on the Regan isoenzyme of alkaline phosphatase in cancer patients. Cancer 1971; 27: 1388
   PubMed Web of Science ®Google Scholar
• Amman R. W., Berk J. E., Fridhandler L., Ueda M., Wegmann W. Hyperamylasemia with carcinoma of the lung. Ann. Intern. Med. 1973; 78: 521
   PubMed Web of Science ®Google Scholar
• Kline E. S., Clayton C. C. Lactic dehydrogenase isozymes during development of azo dye tumors. Cancer Res. 1972; 32: 302
   PubMedGoogle Scholar
• Langvad E., Roed-Peterson B. Studies on oral leukoplakias. XVII. Lactate dehydrogenase patterns in oral leukoplakia. Acta Pathol. Microbiol. Scand. 1969; 75: 193
   PubMedGoogle Scholar
• Hoch-Ligetti C., Grantham H. H., Jr., Arvin J. M. β-Glucuronidase activity in adrenals of patients with or without cancer. Cancer 1969; 24: 796
   PubMed Web of Science ®Google Scholar
• Ababei L., Moisiu M., Chisleag G. Glucose-6-phosphate phosphohydrolase activity in erythrocytes of cancer patients and blood, liver and brain of tumor-bearing rats. J. Natl. Cancer Inst. 1971; 47: 741
   PubMedGoogle Scholar
• Schersten T., Lundholm K. Lysosomal enzyme activity in muscle tissue from patients with malignant tumor. Cancer 1972; 30: 1246
   PubMed Web of Science ®Google Scholar
• Gamklou R., Schersten T. Activity of α-1,4-glucosidase in serum from patients with malignant tumor. Cancer 1973; 32: 298
   PubMed Web of Science ®Google Scholar
• Rapp G. W. Some systemic effects of malignant tumors. Cancer 1973; 31: 357
   PubMed Web of Science ®Google Scholar
• Nakahara W., Fukuoka F. The newer concepts of cancer toxin. Adv. Cancer Res. 1958; 5: 157
   PubMed Web of Science ®Google Scholar
• Uberti J., Johnson R. M., Talley R., Lightbody J. J. Decreased lymphocyte deaminase activity in tumor patients. Cancer Res. 1976; 36: 2046
   PubMed Web of Science ®Google Scholar
• Formeister J. F., Tritsch G. L. Adenosine deaminase levels in blood type A patients with metastatic tumor. Surgery 1976; 79: 111
   PubMed Web of Science ®Google Scholar
• Bodansky O. Enzymes in tumor growth, with special reference to serum enzymes in cancer. Enzymes in Health and Disease, D. M. Greenberg, H. A. Harper. Charles C Thomas, Springfield, Ill. 1960; 269
   Google Scholar
• White L. P. Serum enzymes. III. The significance of abnormalities of glycolytic enzymes in the serum of cancer patients. J. Natl. Cancer Inst. 1958; 21: 685
   PubMedGoogle Scholar
• Wróblewski F. The mechanisms of alteration in lactic dehydrogenase activity of body fluids. Ann. N.Y. Acad. Sci. 1958; 75: 322
   PubMed Web of Science ®Google Scholar
• Wells I. C. Release of intracellular enzymes into serum. Can. J. Biochem. 1969; 47: 347
   PubMedGoogle Scholar
• Boyd J. W. The rates of disappearance of 1-lactate dehydrogenase isoenzymes from plasma. Biochim. Biophys. Acta 1967; 132: 221
   PubMed Web of Science ®Google Scholar
• White L. P. Some enigmas in the comparison of multiple serum enzyme levels. Ann. N.Y. Acad. Sci. 1958; 75: 349
   PubMed Web of Science ®Google Scholar
• Goldman R. D., Kaplan N. O., Hall T. C. Lactic dehydrogenase in human neoplastic tissues. Cancer Res. 1964; 24: 389
   PubMed Web of Science ®Google Scholar
• Hoch-Ligetti C., Brown T. J., Jr., Arvin J. M. Effect of malignant growth on the organ lactic dehydrogenase in the human. Cancer 1965; 18: 1089
   PubMed Web of Science ®Google Scholar
• Hill R. R., Levi C. Elevation of serum component in neoplastic disease. Cancer Res. 1954; 14: 513
   PubMed Web of Science ®Google Scholar
• White L. P. Serum enzymes. II. Glycolytic enzymes in patients with cancer and other diseases. J. Natl. Cancer Inst. 1958; 21: 671
   PubMedGoogle Scholar
• Schwartz M. A., West M., Walsh W. S., Zimmerman H. J. Serum enzymes in disease. VIII. Glycolytic and oxidative enzymes and transaminases in patients with carcinoma of the head, neck and esophagus. Cancer 1962; 15: 346
   Web of Science ®Google Scholar
• Schwartz M. A., Walsh W. S., West M., Zimmerman H. J. Serum enzymes in disease. X. Glycolytic and oxidative enzymes and transaminases in patients with carcinoma of the head, neck and esophagus. Cancer 1962; 15: 927
   PubMed Web of Science ®Google Scholar
• West M., Schwartz M. A., Walsh W. S., Zimmerman H. J. Serum enzymes in disease. XI. Glycolytic and oxidative enzymes and transaminases in patients with cancer of the lung. Cancer 1962; 15: 931
   PubMed Web of Science ®Google Scholar
• Rose A., West M., Zimmerman H. J. Serum enzymes in disease. V. Isocitric dehydrogenase, malic dehydrogenase, and glycolytic enzymes in patients with carcinoma of breast. Cancer 1961; 14: 726
   PubMed Web of Science ®Google Scholar
• Zondag H. A., Klein F. Clinical applications of lactate dehydrogenase isoenzymes: alterations in malignancy. Ann. N.Y. Acad. Sci. 1968; 151: 578
   PubMed Web of Science ®Google Scholar
• Hsieh K. M., Blumenthal H. T. Serum lactic dehydrogenase levels in various disease states. Proc. Soc. Exp. Biol. Med. 1956; 91: 626
   PubMed Web of Science ®Google Scholar
• Bierman H. R., Hill B., Emory E., Reinhardt L. Correlation of serum lactic dehydrogenase activity with the clinical status of patients with neoplastic diseases. Proc. Am. Assoc. Cancer Res. 1955; 2: 5
   Google Scholar
• Gold J. A. Serum enzymes in bronchogenic carcinoma and other pulmonary diseases. Dis. Chest 1961; 39: 62
   PubMedGoogle Scholar
• Hinton J. M. Serum lactate dehydrogenase in bronchial carcinoma. Thorax 1965; 20: 198
   PubMed Web of Science ®Google Scholar
• Bierman H. R., Hill B. R., Reinhardt L., Emory E. Correlation of serum lactic dehydrogenase activity with clinical status of patients with cancer, lymphomas, and the leukemias. Cancer Res. 1957; 17: 660
   PubMed Web of Science ®Google Scholar
• West M., Heller P., Zimmerman H. J. Serum enzymes in disease. III. Lactic dehydrogenase and serum glutamic oxaloacetic transaminase in patients with leukemia and lymphoma. Am. J. Med. Sci. 1958; 235: 689
   PubMed Web of Science ®Google Scholar
• Wróblewski F. Clinical significance of alterations in lactic dehydrogenase activity of body fluids. Am. J. Med. Sci. 1957; 234: 301
   PubMed Web of Science ®Google Scholar
• Hoch-Ligetti C. Effect of irradiation and operation on serum lactic dehydrogenase and glutamic oxalacetic transaminase in patients with malignant tumors. Cancer 1962; 15: 818
   PubMed Web of Science ®Google Scholar
• Stanislawski-Birencwajg M., Loisillier F. Distribution of LDH isoenzymes in mastitis, fibroadenoma, and carcinoma of the human mammary gland. Eur. J. Cancer 1965; 1: 221
   Google Scholar
• Pozanski-Linde H., Wilkinson J. H., Withycombe W. A. Lactate dehydrogenase isoenzymes in malignant tissues. Nature 1966; 209: 727
   PubMed Web of Science ®Google Scholar
• Langvad E. Lactate dehydrogenase isoenzyme patterns in tumor-bearing colon. Int. J. Cancer 1968; 3: 17
   PubMed Web of Science ®Google Scholar
• Barnett H., Gibson A. Lactate dehydrogenase (L.D.H.) isoenzyme patterns in carcinomas of breast. J. Clin. Pathol. 1964; 17: 201
   Web of Science ®Google Scholar
• Yasin R., Bergel F. Lactate dehydrogenase isoenzyme patterns in human normal and malignant gastric mucosa. Eur. J. Cancer 1965; 1: 203
   Google Scholar
• Bohn L., Rothenborg H. W. Lactate dehydrogenase patterns in verruca vulgares, basal cell carcinomas, and malignant melanomas. J. Invest. Dermatol. 1967; 48: 156
   Web of Science ®Google Scholar
• Hou-Jensen K. Lactic acid dehydrogenase isoenzymes in human melanomas. Acta Pathol. Microbiol. Scand. 1967; 70: 196
   PubMedGoogle Scholar
• Kadlecová D., Kolvrář V., Mechl Z. Lacticodehydrogenase isoenzymes in malignant affections. Neoplasma 1967; 14: 473
   Web of Science ®Google Scholar
• Batsakis J. G., Briere R. O. Interpretive Enzymology. Charles C Thomas, Springfield, Ill. 1967; 21
   Google Scholar
• Fujimoto Y., Nazarian I., Wilkinson J. H. Lactate dehydrogenase isoenzyme polymorphism in a patient with secondary carcinoma of the liver. Enzymol. Biol. Clin. 1968; 9: 124
   PubMedGoogle Scholar
• Lundh B. Macromolecular serum lactate dehydrogenase activity in a case of leukemia. Clin. Chim. Acta 1967; 16: 305
   PubMed Web of Science ®Google Scholar
• Markel S. F., Janich S. Complexing of lactate dehydrogenase isoenzymes with immunoglobulin of the kappa class. Am. J. Clin. Pathol. 1974; 61: 328
   PubMed Web of Science ®Google Scholar
• Arai T. Diagnostic and prognostic evaluation of serum lactic dehydrogenase isoenzymes in lung cancer. Tuberc. Leprosy Cancer 1967; 14: 28
   Google Scholar
• Starkweather W. H., Green R. A., Spencer H. H., Schoch H. K. Alterations in serum lactate dehydrogenase isoenzymes during therapy directed at lung cancer. J. Lab. Clin. Med. 1966; 68: 314
   PubMed Web of Science ®Google Scholar
• Wieme R. J., Van Hove W. Z., Van Der Straeten M. E. The influence of cytostatic treatment on serum LDH patterns of patients with bronchial carcinoma and its relation to tumor regression. Ann. N.Y. Acad. Sci. 1968; 151: 213
   PubMed Web of Science ®Google Scholar
• Tan C. O., Cohen J., West M., Zimmerman H. J. Serum enzymes in disease. XIV. Abnormality of levels of transaminases and glycolytic and oxidative enzymes and of liver functions as related to the extent of metastatic carcinoma of the liver. Cancer 1963; 16: 1373
   PubMed Web of Science ®Google Scholar
• Dalluge K.-H., Eichorn H.-J., Ziegenbein R., Huttner J., Richter E. Die Wertigkeit von Serumfermentunter-suchengen für die Erkannung von Rezidiven und/oder Metastasen bösartiger Geschwulste. Dtsch. Gesundheitswes. 1971; 26: 2153
   PubMedGoogle Scholar
• Sato S., Sugimura T., Chien T. C., Takakura K. Aldolase isozyme patterns of human brain tumors. Cancer 1971; 27: 223
   PubMed Web of Science ®Google Scholar
• Tsunematsu K., Yokata S., Shiraishi T. Changes in aldolase isozyme patterns of human cancerous tissues. Gann 1968; 59: 415
   PubMedGoogle Scholar
• Tsunematsu K., Shiraishi T. Aldolase isozyme in human tissue and serum. Cancer 1969; 24: 637
   PubMed Web of Science ®Google Scholar
• Munjal D., Chawla P. L., Lokich J. J., Zamcheck N. Combined measurement of carcinoembryonic antigen (CEA), phosphohexose isomerase (PHI), gamma-glutamyl transpeptidase (γ-GTP) and lactate dehydrogenase in G.I., lung, and breast cancer patients. Proc. Am. Soc. Clin. Oncol. 1975; 16: 200
   Google Scholar
• Lepow H., Schoenfeld M. R., Messeloff C. R., Chie F. Non-prostatic causes of acid hyperphosphatasemia: Report of a case due to multiple myeloma. J. Urol. 1962; 87: 991
   PubMed Web of Science ®Google Scholar
• Gutman A. B., Gutman E. B. An “acid” phosphatase occurring in the serum of patients with metastasizing carcinoma of the prostate. J. Clin. Invest. 1938; 17: 473
   PubMedGoogle Scholar
• Woodard H. Q. The clinical significance of serum acid phosphatase. Am. J. Med. 1959; 27: 902
   PubMed Web of Science ®Google Scholar
• Amador E., Wacker W. E. C. Enzymes in genitourinary disease. Diagnostic Enzymology, E. L. Coodley. Lea & Febiger, Philadelphia 1970; 137
   Google Scholar
• Marshall G., Amador E. Clinical usefulness of serum acid β-glycerophosphatase activities in prostatic disease. Am. J. Clin. Pathol. 1969; 51: 551
   PubMed Web of Science ®Google Scholar
• Doe R. P., Mellinger G. T. Circadian variations of serum acid phosphatase in prostatic cancer. Metab. Clin. Exp. 1964; 13: 445
   PubMed Web of Science ®Google Scholar
• Yogoda A. Non-hormonal cytotoxic agents in the treatment of prostatic adenocarcinoma. Cancer 1973; 32: 1131
   PubMed Web of Science ®Google Scholar
• Duke V. E., Farrow G. M., Green L. F. Prostatic adenocarcinoma of ductal origin. Cancer 1973; 32: 402
   PubMed Web of Science ®Google Scholar
• Mostofi F. K., Price E. B., Jr. Tumors of the Male Genital System, Atlas of Tumor Pathology. 2nd Series, Fascicle 8, Armed Forces Institute of Pathology, Washington, D.C. 1973; 269
   Google Scholar
• Melicow M. M., Tannenbaum M. Endometrial carcinoma of uterus masculinus (prostatic utricle): report of 6 cases. J. Urol. 1972; 106: 892
   Web of Science ®Google Scholar
• Sika J. V., Buckley J. J. Mucus-forming adenocarcinoma of prostate. Cancer 1964; 17: 1949
   Web of Science ®Google Scholar
• Babson A. L., Read P. A. A new assay for prostatic acid phosphatase in serum. Am. J. Clin. Pathol. 1959; 32: 88
   PubMed Web of Science ®Google Scholar
• Fishman W. H., Bonner C. D., Homburger F. Serum “prostatic” acid phosphatase and cancer of the prostate. N. Engl. J. Med. 1956; 255: 925
   PubMed Web of Science ®Google Scholar
• Green S., et al. Automated differential analysis of several serum phosphatase isoenzymes. Automation in Analytical Chemistry, Technicon Symposium, N. B. Scova. Mediad, Inc., White Plains, N.Y. 1967; Vol. 1: 480
   Google Scholar
• Green S., Giovanniello T. J., Cote R. A., Fishman W. H. Automation of total and l-tartrate-sensitive serum phenyl and naphthyl acid phosphatases; their utility in studies of prostatic cancer. Automation in Analytical Chemistry, Technicon Symposium, N. B. Scova, et al. Mediad, Inc., White Plains, N.Y. 1968; Vol. 1: 563
   Google Scholar
• Prout G. R. Diagnosis and staging of prostatic carcinoma. Cancer 1973; 32: 1096
   PubMed Web of Science ®Google Scholar
• Roy A. V., Brower M. E., Hayden J. E. Sodium thymolphthalein monophosphate: a new acid phosphatase substrate with greater specificity for the prostatic enzyme in serum. Clin. Chem. 1971; 17: 1093
   PubMed Web of Science ®Google Scholar
• Goldbert D. M., Ellis G. An assessment of serum acid and alkaline phosphatase determinations in prostatic cancer with a clinical validation of an acid phosphatase assay utilizing adenosine 3′-monophosphate as substrate. J. Clin. Pathol. 1974; 27: 140
   PubMed Web of Science ®Google Scholar
• Murphy G. P., Reynoso G., Kenny G. M., Gaeta J. F. Comparison of total and prostatic fraction serum acid phosphatase levels in patients with differentiated and undifferentiated prostatic carcinoma. Cancer 1969; 23: 1309
   PubMed Web of Science ®Google Scholar
• Ramat B., Streifler C. Serum and tissue acid α-naphthylphosphatase isozymes in various disease. Israel J. Med. Sci. 1967; 3: 505
   PubMedGoogle Scholar
• Reif A. E., Schlesinger R. M., Fish C. A., Robinson C. M. Acid phosphatase isozymes in cancer of the prostate. Cancer 1973; 31: 689
   PubMed Web of Science ®Google Scholar
• Nesbit R. M., Baum W. C. Serum phosphatase determinations in diagnosis of prostatic cancer – a review of 1150 cases. JAMA 1951; 145: 1321
   PubMed Web of Science ®Google Scholar
• Reynolds R. D., Greenberg B. R., Martin N. D., Lucas R. N., Gaffney C. N., Hawn L. Usefulness of bone marrow serum acid phosphatase in staging carcinoma of the prostate. Cancer 1973; 32: 181
   PubMed Web of Science ®Google Scholar
• Kabler R., Farah R., Greenawald K., Cerny J. C. Bone marrow acid phosphatase in the evaluation of patients with carcinoma of the prostate. Henry Ford Hosp. Med. J. 1975; 23: 175
   Google Scholar
• Doe R. P., Mellinger G. T. Circadian variations of serum acid phosphatase in prostatic cancer. Metabolism 1964; 13: 445
   PubMed Web of Science ®Google Scholar
• Winkelman J., Nadler S., Demetriou J., Pileggi V. The clinical usefulness of alkaline phosphatase isoenzyme determinations. Am. J. Clin. Pathol. 1972; 57: 625
   PubMed Web of Science ®Google Scholar
• Brozmanova E., Skrovina B. Serum alkaline phosphatase in malignant bone tumors (osteosarcoma, chondrosarcoma, fibrosarcoma, Ewing's sarcoma). Neoplasma 1973; 20: 419
   PubMed Web of Science ®Google Scholar
• Scranton P. E., Jr., Delicco F. A., Totten R. S., Yunis E. J. Prognostic factors in osteosarcoma. A review of 20 years' experience at the University of Pittsburgh Health Center Hospitals. Cancer 1975; 36: 2179
   PubMed Web of Science ®Google Scholar
• Rosen G., Suwansirikul S., Kwon C., Tan C., Wu S. J., Beattie E. J., Jr., Murphy M. L. High-dose methotrexate with citrovorum factor rescue and adriamycin in childhood osteogenic sarcoma. Cancer 1974; 33: 1151
   PubMed Web of Science ®Google Scholar
• Eisenberg E. Enzymes in bone disease. Diagnostic Enzymology, E. L. Coodley. Lea & Febiger, Philadelphia 1970; 273
   Google Scholar
• Pineda E. P., Goldbarg J. A., Banks B. M., Rutenberg A. M. Serum leucine aminopeptidase in pancreatic and hepatobiliary diseases. Gastroenterology 1960; 38: 698
   PubMed Web of Science ®Google Scholar
• Rutenberg A. M., Pineda E. P., Fischbein J., Goldbarg J. A. A study of serum peptidases in anicteric patients with cancer. Cancer 1964; 17: 781
   PubMed Web of Science ®Google Scholar
• Batsakis J. G., Kremers B. J., Thissen M. M., Schilling J. M. Biliary tract enzymology. A clinical comparison of serum alkaline phosphatase, leucine aminopeptidase and 5′-nucleotidase. Am. J. Clin. Pathol. 1965; 50: 485
   Google Scholar
• Schwartz M. K., Fleisher M., Bodansky O. Clinical application of phosphohydrolase measurements in cancer. Ann. N.Y. Acad. Sci. 1969; 166: 775
   PubMed Web of Science ®Google Scholar
• Batsakis J. G. Serum enzymes and cancer: their use in hepatic metastases. Proc. 1st Invitational Symp. Serodiagnosis of Cancer, Armed Forces Radiobiology Research Institute, Bethesda, Md., 1973; 1
   Google Scholar
• Schwartz M. K., Bethune V. G., Fleisher M. Elevation of serum 5′-nucleotidase, leucine aminopeptidase, and gamma glutamyl transpeptidase in patients with cancer. Clin. Chem. 1973; 19: 655
   Web of Science ®Google Scholar
• Fishman W. H. Immunologic and biochemical approaches to alkaline phosphatase isoenzyme analysis: the Regan isoenzyme. Ann. N.Y. Acad. Sci. 1969; 166: 745
   PubMed Web of Science ®Google Scholar
• Horne M., Cornish C. J., Posen S. Use of urea denaturation in the identification of human alkaline phosphatases. J. Lab. Clin. Med. 1968; 72: 905
   PubMed Web of Science ®Google Scholar
• Fennelly J. J., Dunne J., McGeeney K., Chong L., FitzGerald M. The importance of varying molecular size, differential heat and urea inactivation of phosphatase in the identification of disease patterns. Ann. N.Y. Acad. Sci. 1969; 166: 794
   PubMed Web of Science ®Google Scholar
• Batsakis J. G. Non-specific alkaline phosphatase. Diagnostic Enzymology. American Society of Clinical Pathologists, Chicago 1970; 93
   Google Scholar
• Ramos C. V., Taylor H. B. Hepatic dysfunction associated with renal carcinoma. Cancer 1972; 29: 1287
   PubMed Web of Science ®Google Scholar
• Johnson R. E., Thomas L. B., Johnson S. K., Johnston G. S. Correlation between abnormal baseline liver tests and long-term clinical course in Hodgkin's disease. Cancer 1974; 33: 1123
   PubMed Web of Science ®Google Scholar
• Margolis R., Hansen H. H., Juggia F. M., Kanhouwa S. Diagnosis of liver metastases in bronchogenic carcinoma. A comparative study of liver scans, function tests, and peritoneoscopy with liver biopsy in 111 patients. Cancer 1974; 34: 1825
   PubMed Web of Science ®Google Scholar
• Fishman W. H., Inglis N. R., Stolbach L. L., Krant M. J. A serum alkaline phosphatase isoenzyme of human neoplastic cell origin. Cancer Res. 1968; 28: 150
   PubMed Web of Science ®Google Scholar
• Fishman W. H., Inglis N. R., Green S., Anstiss C. C., Ghosh N. K., Reif A. E., Rustigan R., Krant M. J., Stolbach L. L. Immunology and biochemistry of Regan isoenzyme of alkaline phosphatase in human cancer. Nature 1968; 219: 697
   PubMed Web of Science ®Google Scholar
• Usategui-Gomez M., Yeager F. M., de Castro A. F. A sensitive immunochemical method for the determination of the Regan isoenzyme in serum. Cancer Res. 1973; 33: 1574
   PubMed Web of Science ®Google Scholar
• Cadeau B. J., Blackstein M. E., Malkin A. Increased incidence of placenta-like alkaline phosphatase activity in breast and genitourinary cancer. Cancer Res. 1974; 34: 729
   PubMed Web of Science ®Google Scholar
• Belliveau R. E., Yamamoto L. A., Wassell A. R., Wiernik P. H. Regan isoenzyme in patients with hematopoietic tumors. Am. J. Clin. Pathol. 1974; 62: 329
   PubMed Web of Science ®Google Scholar
• Fishman L., Myayama H., Driscoll S. G., Fishman W. H. Developmental phase-specific alkaline phosphatase isoenzymes of human placenta and their occurrence in human cancer. Cancer Res. 1976; 36: 2268
   PubMed Web of Science ®Google Scholar
• Inglis N. R., Kirley S., Stolbach L. L., Fishman W. H. Phenotypes of the Regan isoenzyme and identity between the placental D-variant and the Nagao isoenzyme. Cancer Res. 1973; 33: 1657
   PubMed Web of Science ®Google Scholar
• Stolbach L. L. Clinical application of alkaline phosphatase isoenzyme analysis. Ann. N.Y. Acad. Sci. 1969; 166: 760
   PubMed Web of Science ®Google Scholar
• Fennelly J. J., Dunne J., McGreeny K., Chong L., FitzGerald M. The importance of varying molecular size, differential heat and urea inactivation of phosphatase in identification of disease patterns. Ann. N.Y. Acad. Sci. 1969; 166: 808
   Web of Science ®Google Scholar
• Sussman H. H., Weintraub B. D., Rosen S. W. Relationship of ectopic placental alkaline phosphatase to ectopic chorionic gonadotropin and placental lactogen. Discordance of three “markers” for cancer. Cancer 1974; 33: 820
   PubMed Web of Science ®Google Scholar
• Temperley W. R. Alkaline phosphatase secreting tumour of lung. Lancet 1968; 2: 356
   Web of Science ®Google Scholar
• Warnock M. L., Reisman R. Variant alkaline phosphatase in human hepatocellular cancers. Clin. Chim. Acta 1969; 24: 5
   PubMed Web of Science ®Google Scholar
• Portugal M. L., Azevedo M. S., Manso L. Serum alpha-fetoprotein and variant alkaline phosphatase in human hepatocellular carcinoma. Int. J. Cancer 1970; 6: 383
   PubMed Web of Science ®Google Scholar
• Romslo I., Bjark P., Solberg C. O. Ectopic alkaline phosphatase production in metastasizing ventricular carcinoma. Scand. J. Clin. Lab. Invest. 1971; 28: 21
   PubMed Web of Science ®Google Scholar
• Warnes T. W., Timperley W. R., Hine P., Kay G. Pancreatic alkaline phosphatase and a tumour variant. Gut 1972; 13: 513
   PubMed Web of Science ®Google Scholar
• Korsten C. B., Persijn J. P., van der Slik W. The application of the serum γ-glutamyl transpeptidase and the 5′-nucleotidase assay in cancer. Z. Klin. Chem. Klin. Biochem. 1974; 12: 116
   PubMedGoogle Scholar
• Dalal F. R., Winsten S. The relation between isoenzymes of gammaglutamyl transpeptidase and leucine aminopeptidase in human serum. Clin. Chem. 1973; 19: 655
   Web of Science ®Google Scholar
• Phillips R. W., Manildi E. R. Abnormal serum isoenzyme of leucine aminopeptidase (LAP) in malignant neoplastic disease. Cancer 1974; 34: 350
   PubMed Web of Science ®Google Scholar
• Tamura Y., Niinobe M., Arima T., Okuda H., Fujii S. Aminopeptidases and arylamidases in normal and cancel tissues in humans. Cancer Res. 1975; 35: 1030
   PubMed Web of Science ®Google Scholar
• Rutenberg A. M., Goldbarg J., Pineda E. P. Leucine aminopeptidase activity. Observations in patients witn cancer of the pancreas and other diseases. N. Engl. J. Med. 1958; 259: 469
   PubMed Web of Science ®Google Scholar
• Phillips R. W., Manildi E. R. Elevation of leucine aminopeptidase in disseminated malignant disease. Cancer 1970; 26: 1006
   PubMed Web of Science ®Google Scholar
• Goldbarg J. A., Rutenberg A. M. The colorimetric determination of leucine aminopeptidase in urine of normal subjects and patients with cancer and other diseases. Cancer 1958; 11: 283
   PubMed Web of Science ®Google Scholar
• Santoni G., Belgeri R., Variati C. V. Attivita leucino-amino-peptidasica urinaria nel corso delle neoplasie maligne dell' apparato genitale femminile (osservazioni su 162 casi). Ann. Ostet. Ginecol. (Milano) 1965; 87: 795
   Google Scholar
• Jacobs W. L. W. Gamma-glutamyl-transpeptidase in diseases of liver, cardiovascular system, and diabetes mellitus. Clin. Chim. Acta 1972; 38: 419
   PubMed Web of Science ®Google Scholar
• Keane P. M., Garcia L., Gupta R. N., Walker W. H. C. Serum gamma-glutamyl transpeptidase in liver disorders. Clin. Biochem. 1973; 6: 41
   PubMed Web of Science ®Google Scholar
• Rutenberg A. M., Goldbarg J. A., Pineda E. P. Serum gamma-glutamyl transpeptidase activity in hepatobiliary pancreatic disease. Gastroenterology 1963; 45: 43
   PubMed Web of Science ®Google Scholar
• Aronsen K. F., Nosslin B., Pihl B. The value of gamma-glutamyl transpeptidase as a screen test for liver tumour. Acta Chir. Scand. 1970; 136: 17
   PubMedGoogle Scholar
• Baden H., Andersen B., Augustenborg G., Hanel H. K. Diagnostic value of gamma-glutamyl transpeptidase and alkaline phosphatase in liver metastases. Surg. Gynecol. Obstet. 1971; 133: 769
   PubMedGoogle Scholar
• Irvin T. T., Edwards J. P., Goligher J. C. The value of plasma gamma-glutamyl transpeptidase in the detection of hepatic metastases. Br. J. Surg. 1973; 60: 347
   PubMed Web of Science ®Google Scholar
• Steele L., Cooper E. H., MacKay A. M., Losowsky M. S., Goligher J. C. Combination of carcinoembryonic antigen and gamma-glutamyl transpeptidase in the study of the evaluation of colorectal cancer. Br. J. Cancer 1974; 30: 319
   PubMed Web of Science ®Google Scholar
• Miyazaki S., Okumura M. Change of serum gamma-glutamyl transpeptidase level and isoenzyme pattern in hepatobiliary pancreatic disease. Clin. Chim. Acta 1972; 40: 193
   PubMed Web of Science ®Google Scholar
• Plaut D., MacQueen J., Soto A., Romero P., Marshall R. A method and clinical study of GGTP isoenzymes. Clin. Chem. 1973; 19: 655
   Web of Science ®Google Scholar
• Dzialoszynski L. M. The clinical value of arylsulfatase estimation in urine. Clin. Chim. Acta 1957; 2: 542
   PubMed Web of Science ®Google Scholar
• Dzialoszynski L. M., Kroll J. L., Frohlick A. Arylsulfatase activity of some malignant tumors. Clin. Chim. Acta 1966; 14: 450
   PubMed Web of Science ®Google Scholar
• Morgan L. R., Reehlmann N. J., Maddux B., Rodriguez L., Gidman G., Samuels M. S., Krementz E. T. Arylsulfatase activity of human lung, liver and kidney neoplasms. Clin. Chim. Acta 1971; 32: 316
   PubMed Web of Science ®Google Scholar
• Morgan L. R., Samuels M. S., Thomas W., Krementz E. T., Meeker W. Arylsulfatase-β in colorectal cancer. Cancer 1975; 36: 2337
   PubMed Web of Science ®Google Scholar
• Morgan L. R., Gillen L. E., Maddux B. E., Krementz E. T. Arylsulfatase in colon-rectal carcinoma and response to 5-fluorourcil. Proc. Am. Assoc. Cancer Res. 1975; 16: 190
   Google Scholar
• Kessel D., Allen J. Elevated plasma sialytransferase in the cancer patient. Cancer Res. 1975; 35: 670
   PubMed Web of Science ®Google Scholar
• Kessel D., Allen J., Henderson M., Brennan M. Elevated plasma sialyltransferase in the cancer patient. Proc. Am. Assoc. Cancer Res. 1975; 16: 100
   Google Scholar
• Osserman E. F., Lawlor D. P. Serum and urinary lysozyme (muramidase) in monocytic and monomyelocytic leukemia. J. Exp. Med. 1966; 124: 921
   PubMed Web of Science ®Google Scholar
• Briggs R. S., Perillie P. E., Finch S. C. Lysozyme in bone marrow and peripheral blood cells. J. Histochem. Cytochem. 1966; 14: 167
   PubMed Web of Science ®Google Scholar
• Perillie P. E., Kaplan S. S., Lefkowitz E., Rogoway W., Finch S. C. Studies of muramidase (lysozyme) in leukemia. JAMA 1968; 203: 317
   Web of Science ®Google Scholar
• Wiernick P. H., Serpick A. A. Clinical significance of serum and urinary muramidase activity in leukemia and other hematologic malignancies. Am. J. Med. 1969; 46: 330
   PubMed Web of Science ®Google Scholar
• Pascual R. S., Gee J. B. L., Finch S. C. Usefulness of serum lysozyme measurement in diagnosis and evaluation of sarcoidosis. N. Engl. J. Med. 1973; 289: 1074
   PubMed Web of Science ®Google Scholar
• Finch S. C., Gnabasik F. J., Rogoway W. Lysozyme and leukopoiesis. Proc. 3rd Symp. Int. sul Lisozima di Fleming, Scuola Arti Grafiche. O. S. F. Cesano Boscone, Milan 1964
   Google Scholar
• Osserman E. F., Lawlor D. P. Serum and urinary lysozyme (muramidase) in monocytic and monomyelocytic leukemia. J. Exp. Med. 1966; 124: 921
   PubMed Web of Science ®Google Scholar
• Jolles P., Sternberg M., Mathe G. Etude de la teneur en lysozyme du serum chez des patients atteints de leucemies et hematosarcomes. Proc. 3rd Symp. Int. Boscone, Milan 1964
   Google Scholar
• Osserman E. F., Lawlor D. P. Serum and urinary lysozyme (muramidase) in monocytic and monomyelocytic leukemia. J. Exp. Med. 1966; 124: 921
   PubMed Web of Science ®Google Scholar
• Youman J. D., III, Saarni M. I., Linman J. W. Diagnostic value of muramidase (lysozyme) in acute leukemia and preleukemia. Mayo Clinic Proc. 1970; 45: 219
   PubMed Web of Science ®Google Scholar
• Pruzanski W., Platts M. E. Serum and urinary proteins, lysozyme (muramidase) and renal dysfunction in monocytic and myelomonocytic leukemia. J. Clin. Invest. 1970; 49: 1694
   PubMed Web of Science ®Google Scholar
• Seligman B. R., Rosner F., Parise F., Lee S. L. Serum muramidase levels in acute leukemia. Am. J. Med. Sci. 1972; 164: 69
   Google Scholar
• Perillie P. E., Finch S. C. Muramidase studies in Philadelphia – chromosome-positive and chromosome-negative chronic granulocytic leukemia. N. Engl. J. Med. 1970; 283: 456
   PubMed Web of Science ®Google Scholar
• Skarin A. T., Matsou Y., Moloney W. C. Muramidase in myeloproliferative disorders terminating in acute leukemia. Cancer 1972; 29: 1336
   PubMed Web of Science ®Google Scholar
• Migliarese J. F. Serum ribonuclease in the cancer patient. Proc. Am. Assoc. Cancer Res. 1958; 2: 327
   Google Scholar
• Levy A. L., Rottino A. Serum ribonuclease levels in malignant and nonmalignant diseases. Proc. Am. Assoc. Cancer Res. 1959; 3: 36
   Google Scholar
• Chretien P. B., Matthews W., Twomey P. L. Serum ribonucleases in cancer: relationship to tumor histology. Cancer 1973; 31: 175
   PubMed Web of Science ®Google Scholar
• Deckers P. J., Pilch Y. H. RNA-mediated transfer of tumor immunity: a new model for immunotherapy of cancer. Cancer 1971; 28: 1219
   PubMed Web of Science ®Google Scholar
• Baylin S. B., Veaven M. A., Biya L. M., Keiser H. R. Histaminase activity: a biochemical marker for medullary carcinoma of the thyroid. Am. J. Med. 1972; 53: 723
   PubMed Web of Science ®Google Scholar
• Baylin S. B., Beaven M. A., Keiser H. R., Tashjian A. H., Jr., Melvin K. E. W. Serum histaminase and calcitonin levels in medullary carcinoma of the thyroid. Lancet 1972; 1: 455
   PubMed Web of Science ®Google Scholar
• Lin C.-W., Orcutt M. L., Stolbach L. L. Elevation of histaminase and its concurrence with Regan isoenzyme in ovarian cancer. Cancer Res. 1975; 35: 2762
   PubMed Web of Science ®Google Scholar
• Fishman W. H., Anylan A. J., Gordon E. The presence of high β-glucuronidase activity in cancer tissue. J. Biol. Chem. 1947; 169: 449
   PubMed Web of Science ®Google Scholar
• Jibril A., Volini F. Lysosomal enzymes in lung disease. Clin. Chem. 1973; 19: 667
   Web of Science ®Google Scholar
• Northup S. N., Stasiw R. O., Brown H. D. Development of the hyaluronidase activity assay as a cancer screening test. Clin. Biochem. 1973; 6: 220
   PubMed Web of Science ®Google Scholar
• Chen Y. M., Chavin W. Serum tyrosinase in malignant disease. Oncology 1975; 31: 147
   PubMed Web of Science ®Google Scholar
• Raab W. P. Enzymes and isoenzymes in urine. Enzymes in Urine and Kidney, U. C. Dubach. Williams and Wilkins, Baltimore 1968; 17
   Google Scholar
• Loughridge L. W., Lewis M. G. Nephrotic syndrome in malignant disease of non-renal origin. Lancet 1971; 1: 256
   PubMed Web of Science ®Google Scholar
• Gault M. H., Geggie P. H. S. Clinical significance of urinary LDH, alkaline phosphatase, and other enzymes. Can. Med. Assoc. J. 1969; 101: 208
   PubMed Web of Science ®Google Scholar
• Grabstaid H., Schwartz M. K. Urinary lactic dehydrogenase in genitourinary tract disease. JAMA 1969; 207: 1062
   Web of Science ®Google Scholar
• Nadel E. M., Altschuler H., Slate T., von Haam E. Feasibility study of combined cytologic and enzymatic lactic acid dehydrogenase (LDH) and alkaline phosphatase (AlkPH) study of urine for bladder cancer. Am. J. Clin. Pathol. 1967; 47: 369
   Web of Science ®Google Scholar
• Gelderman A. H., Gelboin H. V., Peacock A. C. Lactic dehydrogenase isoenzymes in urine from patients with malignancies of the urinary bladder. J. Lab. Clin. Med. 1965; 65: 132
   PubMed Web of Science ®Google Scholar
• Kern W. H., Webster W. W., Bales C. E. Heat fractionation of urine lactic acid dehydrogenase and combined cytopathologic evaluation in the diagnosis of cancer of the urinary tract. J. Urol. 1966; 96: 551
   PubMed Web of Science ®Google Scholar
• Wilkinson J. H. Diagnostic significance of enzyme determinations in urine. Enzymes in Urine and Kidney, U. C. Dubach. Williams and Wilkins, Baltimore 1968; 207
   Google Scholar
• Lewis F. J. W., Plaice C. H. J. Urinary β-glucuronidase activity in cancer of the bladder and other diseases. Br. J. Cancer 1960; 14: 106
   PubMed Web of Science ®Google Scholar
• Melicow M. M., Upson A. C., Lipton R. β-Glucuronidase activity in the urine of patients with bladder cancer and other conditions. J. Urol. 1961; 86: 89
   PubMedGoogle Scholar
• Green J. B., Oldewurtel H. A., Forster F. M. Glutamic oxalacetic transaminase (GOT) and lactic dehydrogenase (LDH) activities – study in cerebrospinal fluid of brain tumor patients in normal human brain, and in brain tumor homogenates. Neurology 1959; 9: 540
   Web of Science ®Google Scholar
• Glennon J. A., Healy M. K. Cerebrospinal fluid lactic acid dehydrogenase – diagnostic significance in neurologic disorders. Conn. Med. 1966; 30: 183
   PubMedGoogle Scholar
• Jakoby R. K., Jakoby W. B. Lactic dehydrogenase of cerebrospinal fluid in the differential diagnosis of cerebrovascular disease and brain tumor. J. Neurosurg. 1958; 15: 45
   PubMed Web of Science ®Google Scholar
• Spolter H., Thompson H. G., Jr. Factors affecting lactic dehydrogenase and glutamic oxalacetic transaminase activities in cerebrospinal fluid. Neurology 1962; 12: 53
   PubMed Web of Science ®Google Scholar
• Van Rymenant M., Robert J., Otten J. Isocitric dehydrogenase in the cerebrospinal fluid – clinical usefulness of its determination. Neurology 1966; 16: 351
   PubMed Web of Science ®Google Scholar
• Davies-Jones G. A. B. Lactate dehydrogenase and glutamic oxalacetic transaminase of the cerebrospinal fluid in tumors of the central nervous system. J. Neurol. Neurosurg. Psychiatry 1969; 32: 324
   PubMed Web of Science ®Google Scholar
• Thompson H. G., Jr., Gellhorn A., Hirschberg E., Osnos M. Evaluation of phosphohexose isomerase activity in cerebrospinal fluid in neoplastic disease of the central nervous system. Neurology 1959; 9: 545
   Web of Science ®Google Scholar
• Herschkowitz N., Cummings J. N. Creatine kinase in cerebrospinal fluid. J. Neurol. Neurosurg. Psychiatry 1964; 27: 247
   PubMed Web of Science ®Google Scholar
• Houck J. C. Cerebrospinal fluid ribonuclease activity. J. Appl. Physiol. 1958; 12: 273
   Web of Science ®Google Scholar
• Anylan A. J., Starr A. β-Glucuronidase activity of spinal and ventricular fluids in humans. Cancer 1952; 5: 578
   PubMed Web of Science ®Google Scholar
• Lehrer G. M. Beta-glucuronidase in cerebrospinal fluid of patients with diseases of the nervous system. Trans. Am. Neurol. Assoc. 1963; 88: 244
   PubMedGoogle Scholar
• Gerhardt W., Clausen J., Christensen E., Rüshede J. Lactate dehydrogenase isoenzymes in the diagnosis of human benign and malignant brain tumors. J. Natl. Cancer Inst. 1967; 38: 343
   PubMedGoogle Scholar
• Sherwin A. L., LeBlanc F. E., McCann W. P. Altered LDH isoenzymes in brain tumors. Arch. Neurol. (Chicago) 1968; 18: 311
   PubMedGoogle Scholar
• Piper D. W., Griffith E. M., Macoun M. L., Broderick F. L., Fenton B. H. Relationship of activities of lactic dehydrogenase, β-glucuronidase and glutamic oxalacetic transaminase in gastric carcinoma to that in fundic and pyloric mucosa. Cancer 1965; 18: 1055
   PubMed Web of Science ®Google Scholar
• Piper D. W., Griffith E. M., Irving L. G., Fenton B. H. Value of β-glucuronidase activity in gastric juice in the diagnosis of gastric carcinoma. Gastroenterology 1966; 51: 172
   PubMed Web of Science ®Google Scholar
• Kim Y. S., Plaut A. G. β-Glucuronidase studies in gastric secretions from patients with gastric cancer. Gastroenterology 1965; 49: 50
   Web of Science ®Google Scholar
• Smyrniotis F., Schenker S., O'Donnell J., Schiff L. Lactic dehydrogenase activity in gastric juice for the diagnosis of gastric cancer. Am. J. Dig. Dis. 1962; 7: 712
   PubMedGoogle Scholar
• Piper D. W., Macoun M. L., Broderick F. L., Fenton B. H., Builder J. E. The diagnosis of gastric carcinoma by the estimation of enzyme activity in gastric juice. Gastroenterology 1963; 45: 614
   PubMed Web of Science ®Google Scholar
• Hill B. R. Some properties of serum lactic dehydrogenase. Cancer Res. 1956; 16: 460
   PubMed Web of Science ®Google Scholar
• Moore A. E., Wroblewski F. Lactic dehydrogenase production in tissue culture of normal, transformed, and malignant human cell lines. Proc. Soc. Exp. Biol. Med. 1958; 98: 786
   PubMed Web of Science ®Google Scholar
• Guttler F., Clausen J. Cellular compartmentalization of lactic dehydrogenase isoenzymes. Enzymol. Biol. Clin. 1967; 8: 456
   Google Scholar
• Wróblewski F. The significance of alterations in lactic dehydrogenase activity of body fluids in the diagnosis of malignant tumors. Cancer 1959; 12: 27
   PubMed Web of Science ®Google Scholar
• Chandrasekhar A. J., Palatao A., Dubin A., Levine H. Pleural fluid lactic dehydrogenase activity and protein content. Arch. Intern. Med. 1969; 123: 48
   PubMedGoogle Scholar
• Jagt T., Lansen O. A. Determination of lactic dehydrogenase in ascitic fluid from patients with malignant tumors. Scand. J. Clin. Lab. Invest. 1960; 12: 200
   PubMed Web of Science ®Google Scholar
• Horrocks J. E., King J., Waind A. P. B., Ward J. Lactate dehydrogenase activity in the diagnosis of malignant effusions. J. Clin. Pathol. 1972; 15: 57
   Google Scholar
• Kirkeby K., Prindz H. Lactic dehydrogenase determinations in pleural and peritoneal effusions. Scand. J. Clin. Lab. Invest. 1959; 11: 185
   Web of Science ®Google Scholar
• de Torregrosa M. V. Results of lactic dehydrogenase determinations in benign and malignant effusions. Am. J. Med. Sci. 1959; 238: 551
   Web of Science ®Google Scholar
• Brauer M. J., West M., Zimmerman H. J. Serum enzymes in disease. XIII. Comparison of glycolytic and oxidative enzyme and transaminase values in benign and malignant effusions with those in serums. Cancer 1963; 16: 533
   PubMed Web of Science ®Google Scholar
• Johnson W. D. The cytologic diagnosis of cancer in serous effusions. Acta Cytol. 1966; 10: 161
   PubMed Web of Science ®Google Scholar
• Spriggs A. I., Boddington M. M. The Cytology of Effusions in the Pleural, Pericardial, and Peritoneal Cavities and of Cerebrospinal Fluids. William Heinemann, London 1968
   Google Scholar
• Stagg B. H., Whyley G. A. Some characteristics of lactate dehydrogenase isoenzymes in tumours of the female genital tract. Clin. Chim. Acta 1968; 22: 521
   PubMed Web of Science ®Google Scholar
• Odell L. D., Burt J. C. New diagnostic adjunct for uterine cancer. JAMA 1950; 142: 226
   PubMed Web of Science ®Google Scholar
• Lawson J., Watkins D. K. Vaginal fluid enzymes in relation to cervical cancer. J. Obstet. Gynaecol. Br. Commonw. 1965; 72: 1
   PubMedGoogle Scholar
• Kasdon S. C., Homburger F., Yorshis E., Fishman W. A. Beta-glucuronidase studies in women. VI. Premenopausal vaginal fluid values in relation to invasive cervical cancer. Surg. Gynecol. Obstet. 1953; 97: 579
   PubMedGoogle Scholar
• Fishman W. H., Green S., Homburger F., Kasdon S. C., Nieburgs H. E., McInnis G., Pund E. R. β-Glucuronidase studies in women. VII. Pre-menopausal vaginal-fluid-β-glucuronidase values in relation to in situ cancer of the cervix. Cancer 1954; 7: 729
   PubMed Web of Science ®Google Scholar
• Hatzimichael A. Comparison of vaginal and cervical beta-glucuronidase in relation to cancer of the cervix and uterus. Am. J. Obst. Gynec. 1962; 84: 94
   PubMed Web of Science ®Google Scholar
• Bonham D. G., Gibbs D. A new enzyme test for gynaecological cancer. Br. Med. J. 1962; 2: 823
   PubMedGoogle Scholar
• Moukhtar M., Higgins G. The early diagnosis of carcinoma of the female genital tract. J. Obstet. Gynaecol. Br. Commonw. 1965; 72: 667
   Google Scholar
• Hoffman R. L., Merritt J. W. 6-Phosphogluconate dehydrogenase in uterine cancer detection. Am. J. Obstet. Gynecol. 1965; 92: 650
   PubMed Web of Science ®Google Scholar
• Wooton I. D. P., Shepperd Y. The use of an enzyme test as a primary screening test for gynaecological cancer. J. Obstet. Gynaecol. Br. Commonw. 1967; 74: 270
   PubMedGoogle Scholar
• Cameron C. B., Husain O. A. N. 6-Phosphogluconate dehydrogenase activity in vaginal fluid: limitations as a screening test for genital cancer. Br. Med. J. 1965; 1: 1529
   PubMedGoogle Scholar
• Bell J., Edgerton M. E. 6-Phosphogluconate dehydrogenase estimation in vaginal fluid in the diagnosis of cervical cancer. J. Obstet. Gynaecol. Br. Commonw. 1966; 72: 603
   Google Scholar
• Sanner T., Bergsjo P., Koller O., Kolstad P., Pihl A. Technical modifications of the 6-phosphogluconate dehydrogenase test of the vaginal fluid. Am. J. Obstet. Gynecol. 1967; 98: 800
   PubMed Web of Science ®Google Scholar
• Sanner T., Bentzen H., Kolstad P., Nordby K., Pihl A. The alleged usefulness of 6-phosphogluconate dehydrogenase determinations in screening for uterine cancer. Acta Obstet. Gynecol. Scand. 1970; 49: 371
   PubMed Web of Science ®Google Scholar
• LePage G. A. Alterations in enzyme activity in tumors and the implications for chemotherapy. Adv. Enzyme Regul. 1970; 8: 323
   PubMedGoogle Scholar
• Young C. personal communication; cited by Yogoda, A., Non-hormonal cytotoxic agents in the treatment of prostatic adenocarcinoma. Cancer 1973; 32: 1131
   PubMed Web of Science ®Google Scholar
• Nadel E., Mantel N., Kaplan N., Altschuler H. Individuality in serum lactic dehydrogenase (LDH) activity in aged persons: significance for cancer diagnosis. Ann. N.Y. Acad. Sci. 1969; 16: 1581
   Google Scholar